Pesquisas alternativas:
development types » development type (Expandir a Pesquisa), development times (Expandir a Pesquisa), development time (Expandir a Pesquisa)
de development » de developpment (Expandir a Pesquisa), de developpement (Expandir a Pesquisa), node development (Expandir a Pesquisa)
models develop » model develop (Expandir a Pesquisa), models developed (Expandir a Pesquisa), model develops (Expandir a Pesquisa)
develop type » developing type (Expandir a Pesquisa)
drug models » drug mode (Expandir a Pesquisa)
drug de » drug dose (Expandir a Pesquisa), drug dna (Expandir a Pesquisa)
development types » development type (Expandir a Pesquisa), development times (Expandir a Pesquisa), development time (Expandir a Pesquisa)
de development » de developpment (Expandir a Pesquisa), de developpement (Expandir a Pesquisa), node development (Expandir a Pesquisa)
models develop » model develop (Expandir a Pesquisa), models developed (Expandir a Pesquisa), model develops (Expandir a Pesquisa)
develop type » developing type (Expandir a Pesquisa)
drug models » drug mode (Expandir a Pesquisa)
drug de » drug dose (Expandir a Pesquisa), drug dna (Expandir a Pesquisa)
1
Por Kitamoto, Tetsuyuki., International Symposium of Prion Diseases for Food and Drug Safety
Publicado em 2005
“... (vCJD) in the United Kingdom. In 2004, the International symposium of prion diseases for food and drug...”Publicado em 2005
Obter o texto integral
Livro
2
Por Ritchwood, Tiarney D., DeCoster, Jamie, Metzger, Isha, Bolland, John M., Danielson, Carla K.
Publicado no Addict Behav (2016)
“... the consideration of type of SU, and particular combinations of substances, on RSBs in intervention development....”Publicado no Addict Behav (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
3
Por Jardim, Denis L., de Melo Gagliato, Débora, Giles, Francis J., Kurzrock, Razelle
Publicado no Clin Cancer Res (2017)
“... drug development/approval models on the accuracy of safety and efficacy assessments by searching the US...”Publicado no Clin Cancer Res (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
4
Por S. Ferreira, Guilherme, Veening-Griffioen, Désirée H., Boon, Wouter P. C., Moors, Ellen H. M., Gispen-de Wied, Christine C., Schellekens, Huub, van Meer, Peter J. K.
Publicado no PLoS One (2019)
“... and unnecessary attrition in drug development. OBJECTIVES: To develop a tool to assess, validate and compare...”Publicado no PLoS One (2019)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
5
Por de Boer, Richard, Smith, Ruben L., De Vos, Winnok H., Manders, Erik M. M., Brul, Stanley, van der Spek, Hans
Publicado no PLoS One (2015)
“... is crucial. We therefore set out to develop the use of Caenorhabditis elegans to study drug induced...”Publicado no PLoS One (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
6
Por Yacelis Dahilet Cisneros Nápoles, Pedro Milián Vázquez, Maira Quiroz Enríquez, Yaikibel Soto Navarro, Moraima Pérez Fonseca, Eidys Rodríguez Herrera
Publicado em 2014-04-01
Assuntos:
“...educación de postgrado en medicina...”Publicado em 2014-04-01
Obter o texto integral
Artigo
7
Por Rencus-Lazar, Sigal, DeRowe, Yasmin, Adsi, Hanaa, Gazit, Ehud, Laor, Dana
Publicado no Front Mol Biosci (2019)
“... cytotoxicity. The canonical yeast models have recently been expanded by the establishment of a model for type...”Publicado no Front Mol Biosci (2019)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
8
Por Huang, Fangjin, Ma, Zhaoxuan, Pollan, Sara, Yuan, Xiaopu, Swartwood, Steven, Gertych, Arkadiusz, Rodriguez, Maria, Mallick, Jayati, Bhele, Sanica, Guindi, Maha, Dhall, Deepti, Walts, Ann E, Bose, Shikha, de Peralta Venturina, Mariza, Marchevsky, Alberto M, Luthringer, Daniel J, Feller, Stephan M, Berman, Benjamin, Freeman, Michael R, Alvord, W Gregory, Vande Woude, George, Amin, Mahul B, Knudsen, Beatrice S
Publicado no J Pathol Clin Res (2016)
“... specific antibody selection and should be developed in those cancer types in which they are employed...”Publicado no J Pathol Clin Res (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
9
Por Xie, Yingda, Via, Laura, Chen, Ray, Dodd, Lori, Cai, Ying, Paripati, Paveen, Goldfeder, Lisa, Winter, Jill, Arora, Kriti, Wang, Jing, De Jagar, Veronique, Malherbe, Stephanus, Song, Taeksun, Walzl, Gerhard, Diacon, Andreas, III, Clifton Barry
Publicado no Open Forum Infect Dis (2018)
“...BACKGROUND: Current Phase 2a methods in tuberculosis (TB) drug development are severely limited...”Publicado no Open Forum Infect Dis (2018)
Obter o texto integral
Obter o texto integral
Artigo
10
Por Stilianakis, N I, Boucher, C A, De Jong, M D, Van Leeuwen, R, Schuurman, R, De Boer, R J
Publicado em 1997
“.... We develop a mathematical model for this situation. The model distinguishes quiescent from activated...”Publicado em 1997
Obter o texto integral
Obter o texto integral
Artigo
11
“... and adequate antiadenovirus compounds. Since human adenoviruses are species specific, animal models...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
12
Por Sigal Rencus-Lazar, Yasmin DeRowe, Hanaa Adsi, Ehud Gazit, Ehud Gazit, Ehud Gazit, Dana Laor
Publicado em 2019-03-01
Assuntos:
“...yeast models...”Publicado em 2019-03-01
Obter o texto integral
Artigo
13
Por Johnson, Amy J., Lucas, David M., Muthusamy, Natarajan, Smith, Lisa L., Edwards, Ryan B., De Lay, Michael D., Croce, Carlo M., Grever, Michael R., Byrd, John C.
Publicado em 2006
“...Drug development in human chronic lymphocytic leukemia (CLL) has been limited by lack of a suitable...”Publicado em 2006
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
14
A human liver microphysiology platform for investigating physiology, drug safety, and disease models
Por Vernetti, Lawrence A, Senutovitch, Nina, Boltz, Robert, DeBiasio, Richard, Ying Shun, Tong, Gough, Albert, Taylor, D Lansing
Publicado no Exp Biol Med (Maywood) (2015)
“...This paper describes the development and characterization of a microphysiology platform for drug...”Publicado no Exp Biol Med (Maywood) (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
15
Por Brun, Susana, Schall, Nicolas, Jeltsch-David, Hélène, de Sèze, Jérôme, Muller, Sylviane
Publicado no Cells (2017)
“... with the S-palmitoylated P0(180-199) peptide develop a chronic, sometimes relapsing-remitting type of disease. Our model...”Publicado no Cells (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
16
Por Stolpe, Anja van de, Holtzer, Laurent, van Ooijen, Henk, de Inda, Marcia Alves, Verhaegh, Wim
Publicado no Sci Rep (2019)
“...Signal transduction pathways are important in physiology and pathophysiology. Targeted drugs aim...”Publicado no Sci Rep (2019)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
17
Por Dooko, Claude Béténé A, De Wit, Stephane, Neuhaus, Jacqueline, Palfreeman, Adrian, Pepe, Rosalie, Pankow, James S., Neaton, James D.
Publicado no J Acquir Immune Defic Syndr (2014)
“... is hypothesized to play a role in the development of type 2 diabetes. Data addressing this issue among HIV...”Publicado no J Acquir Immune Defic Syndr (2014)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
18
Por Deshpande, Laxmikant S., Blair, Robert E., Nagarkatti, Nisha, Sombati, Sompong, Martin, Billy R., DeLorenzo, Robert J.
Publicado em 2007
“... neuronal cultures and in agreement with animal models and human SE confirm the development of resistance...”Publicado em 2007
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
19
Por Lyzogubov, Valeriy V., Bora, Puran S., Wu, Xiaobo, Horn, Leah E., de Roque, Ryan, Rudolf, Xeniya V., Atkinson, John P., Bora, Nalini S.
Publicado no Am J Pathol (2016)
“... should provide valuable insights into pathogenesis and a test model system for novel drug targets. More...”Publicado no Am J Pathol (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
20
Por Goossens, Maria E., Buntinx, Frank, Zeegers, Maurice P., Driessen, J.H.M., De Bruin, Marie L., De Vries, Frank
Publicado no Br J Clin Pharmacol (2015)
“...‐diabetic drugs (ADD) and/or insulin. The risk of UBC in different groups of ADD users (metformin alone (one...”Publicado no Br J Clin Pharmacol (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo